Q3 2026 earnings calendar: consensus revenue and EPS for eight companies

what happened

According to TradingView, citing FactSet, Bionano Genomics (BNGO), Cellectar Biosciences (CLRB), Cytosorbents (CTSO), Karyopharm Therapeutics (KPTI) and NextCure (NXTC) are scheduled to report third-quarter 2026 results on October 29, with disclosure expected at 8:00 AM ET. Consensus expects a loss of 0.45 USD per share for BNGO on revenue of about 8.44 million USD, a loss of 0.56 USD for CLRB with no revenue estimate, a loss of 0.90 USD for CTSO on 9.90 million USD in revenue, a loss of 0.95 USD for KPTI on 33.54 million USD, and a loss of 0.90 USD for NXTC.

MacroGenics (MGNX) reports on November 4 at 7:00 AM ET, with revenue estimated at 39.18 million USD and a loss of 0.32 USD per share. Red Robin Gourmet Burgers (RRGB) is expected to post revenue of 251.67 million USD and a loss of 0.36 USD per share, while Stoneridge (SRI) is forecast at 178.73 million USD in revenue and 0.07 USD per share in earnings. Both report on November 4 after the market closes.

why it matters

These are routine earnings calendar entries for small companies, so each has limited impact on the broad market. For investors in small-cap biotech and in the restaurant and auto-parts sectors, the dates and consensus figures serve as a reference point when actual results come out.

tags

instruments